Sort by
Refine Your Search
-
Employer
- Deutsches Zentrum für Neurodegenerative Erkrankungen e. V. (DZNE)
- Forschungszentrum Jülich
- German Center for Neurodegenerative Diseases (DZNE)
- Hannover Medical School •
- Leibniz
- Ludwig-Maximilians-Universität München •
- ; German Cancer Research Center (DKFZ)
- DAAD
- Fraunhofer-Gesellschaft
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Max Planck Institute for Infection Biology •
- University of Duisburg-Essen •
- 2 more »
- « less
-
Field
-
At the Leibniz Institute for Prevention Research and Epidemiology – BIPS we have an opening in the Department of Biometry and Data Management within the Research Group “Statistical Methods
-
Winter and summer semester Application deadline It is possible to apply any time (via e-mail only, phd-epidemiology@helmholtz-hzi.de ), provided that all requirements are fulfilled (see prerequisites
-
, development and differentiation of immune cells and infectious disease epidemiology. Max Planck Institute for Infection Biology The Max Planck Society is Germany's most successful research organisation. With 30
-
, computational biology, computer science, epidemiology/public health studies and related subjects are invited to apply for the international PhD programme. PhD students are supported by a Thesis Advisory Committee
-
“REBIRTH” in 2007), Auditory Sciences (from the Excellence Cluster "Hearing4all" in 2013), Epidemiology (since 2013) and Biomedical Data Science (BIOMEDAS since 2020). In addition, we offer three Master's
-
Description/content Infectious diseases and inflammatory disorders (including HIV, TB, and malaria) epidemiology public health health systems research occupational safety and health mother and child health non
-
2535) Therapeutic Radiation in Cancer (RTG 2762) PhD Epidemiology and Clinical Research Treatment Expectation (CRC 289) Local Thyroid Hormone Action (CRC 296) Cell State Transitions (CRC 1430) In
-
. This is achieved by joining the disciplines of pharmacy and medicine as well as cooperating with specialists within epidemiology, public health, and healthcare research. Different aspects of drug safety